GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (CHIX:CURNz) » Definitions » Deferred Tax

Curatis Holding AG (CHIX:CURNZ) Deferred Tax : CHF-1.42 Mil (TTM As of Jun. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Curatis Holding AG Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Curatis Holding AG's change in deferred tax for the six months ended in Jun. 2024 was CHF-0.07 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Jun. 2024 was CHF-1.42 Mil.

Curatis Holding AG Deferred Tax Historical Data

The historical data trend for Curatis Holding AG's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curatis Holding AG Deferred Tax Chart

Curatis Holding AG Annual Data
Trend Dec21 Dec22 Dec23
Deferred Tax
- -5.16 -1.38

Curatis Holding AG Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Deferred Tax Get a 7-Day Free Trial - - -0.04 -1.35 -0.07

Curatis Holding AG Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-1.42 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curatis Holding AG Deferred Tax Related Terms

Thank you for viewing the detailed overview of Curatis Holding AG's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Curatis Holding AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (CHIX:CURNz) » Definitions » Deferred Tax
Comparable Companies
ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA SHSE:688506 BOM:500087 TSE:4507 SZSE:000538 UTHR NSE:TORNTPHARM BOM:543904 BOM:500124 BOM:500257 NBIX
Traded in Other Exchanges
CURN:Switzerland
Address
Weierweg 7, Liestal, CHE, CH-4410
Website
https://www.curatis.com
Curatis Holding AG is a specialty pharmaceutical company based in Switzerland. It focus on the acquisition, development and commercialisation of medicines for the prevention, diagnosis and treatment of rare and specialty care diseases. Curatis is engaged in two business areas: Distribution business for orphan disease and specialty care medicines and Development business for orphan and specialty care disease medicines. Its product include Aggrastat (Tirofiban), AmbiFul (Fulvestrant), Brinavess (Vernakalant), Coldistop, Cuprior (Trientin), Cyanokit (Hydroxocobalamin), etc.

Curatis Holding AG Headlines

No Headlines